Heidelberg Pharma Research is a biopharmaceutical company that develops cancer therapies using antibody-drug conjugates targeting antibodies with potent toxins to eliminate tumor cells. The company builds ADC candidates and collaborates with partners, applying the technology across multiple cancer types while advancing research, development, and